Development of pH-sensitive nanoparticles that are capable of capturing WIP1 and miR-21 inhibitors will aid in paving the way for effective future therapeutic approaches against trastuzumab-resistant breast cancers [177]. The gene discussed is PPM1D; the disease is breast carcinoma.